NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
NRC HEALTH
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$20.47+0.32 (+1.59%)
Close on Oct 19, 2026
- Market cap
- $450.52M
- P/E (TTM)
- 0.4
- Dividend yield
- 2.54%
Nrc Health statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Commercial Physical & Biological Research companies for comparison
Valuation
| Measure | Nrc Health | Industry median |
|---|---|---|
| Market Cap | $452.79M | $74.60M |
| Enterprise Value | $539.49M | $56.72M |
| PS Ratio | 3.23 | 3.25 |
| PB Ratio | 69.14 | 3.13 |
| P/FCF Ratio | 20.92 | 20.60 |
| P/OCF Ratio | 15.34 | 15.81 |
Enterprise value
| Measure | Nrc Health | Industry median |
|---|---|---|
| EV / Sales | 3.85 | 2.79 |
| EV / EBITDA | 23.09 | 15.81 |
| EV / EBIT | 36.61 | 22.04 |
| EV / FCF | 24.93 | 21.35 |
Income (trailing twelve months)
| Measure | Nrc Health | Industry median |
|---|---|---|
| Revenue | $140.00M | $24.74M |
| Operating Income | $14.74M | -$55.64K |
| Pretax Income | $9.38M | $45.62K |
| EBITDA | $23.37M | -$29.48K |
Margins
| Measure | Nrc Health | Industry median |
|---|---|---|
| Operating Margin | 10.5% | 0.94% |
| Pretax Margin | 6.70% | 2.64% |
| EBITDA Margin | 16.7% | 3.48% |
| FCF Margin | 15.5% | 5.05% |
Returns
| Measure | Nrc Health | Industry median |
|---|---|---|
| Return on Invested Capital (ROIC) | 9.88% | 2.85% |
| Return on Capital Employed (ROCE) | 14.6% | 2.03% |
Growth
| Measure | Nrc Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -0.23% | 4.26% |
| FCF Growth (YoY) | 133.4% | -10.5% |
| Revenue Growth (3Y CAGR) | -3.22% | 2.15% |
| Revenue Growth (5Y CAGR) | 0.61% | 7.37% |
| EPS Growth (3Y CAGR) | 240.2% | 6.08% |
| EPS Growth (5Y CAGR) | 103.0% | 9.81% |
Balance sheet
| Measure | Nrc Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $3.33M | $5.43M |
| Total Debt | $90.03M | $85.44M |
| Net Cash (Debt) | -$86.70M | $17.62K |
| Net Cash Per Share | -$3.92 | $0.00 |
| Equity (Book Value) | $6.55M | $10.50M |
| Book Value Per Share | $0.30 | $0.60 |
| Tangible Book Value | -$61.71M | -$78.36K |
| Working Capital | -$12.21M | $2.78M |
Financial position
| Measure | Nrc Health | Industry median |
|---|---|---|
| Current Ratio | 0.65 | 1.26 |
| Quick Ratio | 0.36 | 0.65 |
| Debt / Equity | 13.75 | 0.45 |
| Debt / EBITDA | 3.85 | 2.59 |
| Debt / FCF | 4.16 | 3.29 |
| Net Debt / EBITDA | 3.71 | 1.99 |
| Interest Coverage | 2.73 | -0.23 |
Cash flow (trailing twelve months)
| Measure | Nrc Health | Industry median |
|---|---|---|
| Operating Cash Flow | $29.51M | $8.04K |
| Capital Expenditures | -$7.87M | -$8.33M |
| Free Cash Flow | $21.64M | $11.03M |
| FCF Per Share | $0.98 | $0.76 |
Efficiency
| Measure | Nrc Health | Industry median |
|---|---|---|
| Asset Turnover | 1.01 | 0.83 |
| Revenue Per Employee | $392.15K | $216.23K |
| Employee Count | 357 | 123 |
Dividends and yields
| Measure | Nrc Health | Industry median |
|---|---|---|
| FCF Yield | 4.78% | 3.90% |
| Dividend Yield | 2.54% | 1.80% |
| Buyback Yield | 4.16% | 1.36% |
| Shareholder Yield | 6.70% | 1.65% |
| Dividend Per Share | $0.52 | $0.52 |
| Dividend Growth (YoY) | 8.33% | 7.42% |
| Years of Dividend Growth | 1 | 1 |
| FCF Payout Ratio | 58.7% | 30.1% |
Shares
| Measure | Nrc Health | Industry median |
|---|---|---|
| Shares Outstanding | 22,119,600 | 29,217,800 |
| Shares Change (YoY) | -5.26% | 0.84% |
| Shares Change (QoQ) | -1.76% | 0.00% |
| Float | 10,682,800 | 26,226,050 |
| Shares Held by Insiders | 51.7% | 4.85% |
| Shares Held by Institutions | 48.6% | 83.3% |
Taxes
| Measure | Nrc Health | Industry median |
|---|---|---|
| Income Tax | $3.53M | $1.36M |
| Effective Tax Rate | 37.6% | 23.6% |
Scores
| Measure | Nrc Health | Industry median |
|---|---|---|
| Altman Z-Score | 3.12 | 2.66 |
Calculated by StockData from Nrc Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.